in 12 patients with coronary artery disease , 11 of them with previous myocardial infarction , the antiarrhythmic effects of orally administered flecainide ( f. ) , mexiletine ( m. ) and propafenone ( p. ) were examined .
C0003195
antiarrhythmic
C0016229
flecainide